J-TEC develops autologous CART therapy for acute lymphoblastic leukemia
With a license from Nagoya University and Shinshu University, J-TEC plans to develop, manufacture and market its own CART for CD19 positive acute lymphoblastic leukemia (ALL). The CART developed uses the piggyBac transposon method, a non-viral vector which introduces the CAR gene into T cells. Because the piggyBac transposon method does not use a virus, […]